VERTEX PHARMACEUTICALS INC / MA
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
EVP, CP and NPPO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP & Chief Accounting Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
EVP, Chief Reg. & Quality Off.
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP Chief Patient & Ext Af Off
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Deferred Stock Units
Derivative security · not the ordinary share price.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, CP and NPPO | Common StockGrant or award | 8,682Award · no purchase price | Non-cash award | Sep 8Filed Sep 10 · 2d later | SEC filing |
| SVP & Chief Accounting Officer | Common StockGrant or award | 5,000Award · no purchase price | Non-cash award | Aug 28Filed Sep 1 · 4d later | SEC filing |
| Director | Common StockGift | 6,000Gift · no purchase price | Not a purchase | Aug 27Filed Aug 31 · 4d later | SEC filing |
| EVP, Chief Reg. & Quality Off. | Common StockGrant or award | 8,251Award · no purchase price | Non-cash award | Jul 21Filed Jul 23 · 2d later | SEC filing |
| EVP Chief Patient & Ext Af Off | Common StockGrant or award | 8,251Award · no purchase price | Non-cash award | Jul 21Filed Jul 23 · 2d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units100$475.28 / derivative unit | $47.5K | Jul 15Filed Jul 17 · 2d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units32$475.28 / derivative unit | $15K | Jul 15Filed Jul 17 · 2d later | SEC filing |
| Director | Common StockDisposition to issuer | 796Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units2,866Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units796Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockGrant or award | 472Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockDisposition to issuer | 398Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,433Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units398Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockGrant or award | 472Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockDisposition to issuer | 796Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,433Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Deferred Stock UnitsGrant or award | Derivative units796Price not reported | Unavailable | May 1Filed May 5 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units2,866Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
| Director | Common StockGrant or award | 943Award · no purchase price | Non-cash award | May 1Filed May 5 · 4d later | SEC filing |
Showing the latest 20 of 30 trades. Show all 30 trades
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a full sale for a joint account.
Thomas H TubervilleReporting Senate memberVertex Pharmaceuticals Incorporated - Common Stock · Stock
The filing reports a purchase for the member.
Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a sale for the member.
David J. TaylorReporting House memberVertex Pharmaceuticals Incorporated - Common Stock (VRTX) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
